Scientists track Cancer's secret moves to dodge immune drugs
NCT ID NCT02724488
Summary
This study aims to understand how advanced cancers like melanoma and head/neck cancer change and evolve when treated with immunotherapy drugs. Researchers will collect tumor biopsies and blood samples from a small group of patients at different points during their treatment. The goal is to learn how tumors adapt and potentially become resistant, which could inform future treatment strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.